Explore 3 Stock Ideas & Industry Insights Download Free Report

Whitehawk Therapeutics, Inc.

Company price
3.17 USD 0.07 ( 2.26%)
Last update at 2026-11-04T21:00:00Z
VOLUME
468122
Market Cap
0.00M

Momentum Score

…

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
3.11
Low
3.38
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Whitehawk Therapeutics, Inc. is a Nasdaq-listed development-stage biopharmaceutical company with a pipeline of therapeutic candidates disclosed in its public filings. Long-term growth could be supported by successful clinical readouts, regulatory approvals, and business development that advance commercialization. The company may appeal to investors seeking exposure to clinical-stage biotech upside.

Material risks include the high likelihood of clinical or regulatory setbacks, ongoing financing needs that may dilute shareholders, and competitive pressures in its therapeutic areas.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
3.10
Dividend Yield
-
Revenue TTM
-
Revenue Per Share
-
Gross Profit TTM
-
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
-
Diluted EPS TTM
-

Peer Comparison*

Sector: Industry:

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
WHWK
Whitehawk Therapeutics, Inc.
0.07
2.26%
3.17 - - - -

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…